- The opioid epidemic has become a worldwide crisis, with more than 130 people dying every day from an overdose in the U.S. alone
- The psychedelics industry has shown to be a significant player in combatting the opioid crisis and is currently $200 million worth of investments
- It’s not just the addict who’s affected. It’s their family and friends as well – and communities
- Universal Ibogaine Inc. has a plan to curb the number of opioid-related deaths through its plant-based treatment approach
North America has been ravaged by the opioid crisis with people unknowingly consuming highly potent and dangerous substances legally prescribed. This has led to a rise in overdoses — currently, the number one reason people are dying under 50. The volume of medical emergencies in Vancouver’s Eastside alone would be a significant cause for concern, but the problem extends across all of Canada and the U.S.